Immunologie-Virologie, EA 3038, Université Paul Sabatier, 31062 Toulouse,1 Immunité & Infections Virales, CNRS-UCBL UMR 5537, IFR Laennec, 69372 Lyon Cedex 08, France2
SUMMARY INTRODUCTION DEFINITION OF RAFTS Composition of Rafts Functions of Rafts RAFTS AS PLATFORMS FOR VIRUS ENTRY Nonenveloped Viruses Enveloped Viruses RAFTS AS PLATFORMS FOR VIRUS ASSEMBLY Nonenveloped Viruses Enveloped Viruses RAFTS AS PLATFORMS FOR VIRUS BUDDING Gateway for Budding Viruses Recruitment of Cellular Machinery Needed for Virus Budding CONCLUDING REMARKS AND PROSPECTS ACKNOWLEDGMENTS REFERENCES
| SUMMARY |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
In this review, we focus on data supporting the involvement of membrane rafts in the virus replication cycle, their role as a viral entry site, a platform for the assembly of viral components, and a scaffold for the budding of virus from infected cells. The elucidation of these interactions requires a detailed understanding of raft structures and dynamics.
| DEFINITION OF RAFTS |
|---|
|
|
|---|
In addition to biochemical fractionation, several lines of evidence support the in vivo existence of rafts (30, 38, 55). Their in vivo size has been estimated to be between 25 and 700 nm by using fluorescence resonance energy transfer microscopy and single-molecule-tracking microscopy (55, 94, 104, 116). Many, but not all, proteins anchored to the membrane by a lipid moiety associate with membrane rafts. They include the glycosylphosphatidylinositol (GPI)-anchored proteins, which are located on the extracellular leaflet, and palmitoylated or doubly acetylated proteins, which are enriched in the inner cytoplasmic leaflet. However, geranylated proteins are excluded from rafts (see references 48, 105, and 107 for reviews).
Several data point to the existence of different subsets of rafts depending on the combinatorial association of different sphingolipid species with cholesterol and protein contents (72, 104). One particular membrane raft subset is caveolae. Present in many mammalian cells except lymphocytes and neurons, caveolae are 50- to 70-nm plasma membrane invaginations which are surrounded by a striated coat made of the 22-kDa caveolins tightly bound to cholesterol (77). Likewise, some bona fide membrane rafts are soluble in 1% TX-100 yet insoluble in a lower concentration of TX-100 or in other nonionic detergents, e.g., Brij or Lubrol (98).
Several techniques to study and characterize membrane rafts have been described in the literature. The simplest one is to collect the pellet from a cell extract solubilized with 1% TX-100 at 4°C and centrifuged at 10,000 x g. This technique is not reliable because only the "heaviest" raft structures, which are contaminated with unsoluble material such as protein aggregates, are collected. The classical biochemical experiment involves flotation on a density (sucrose or iodixanol) gradient, with the cell extract being loaded at the bottom of the gradient. The quality of the separation should be checked using bona fide raft and nonraft markers. The alternative approach is to study the colocalization of a protein with a raft marker by microscopic examination (confocal microscopy, fluoresence resonance energy transfer microscopy, electron microscopy, etc.). However, in most cases, rafts are visualized only after clustering of one of the raft components. In any case, disruption of the membrane rafts by treatment of the cells with a cholesterol chelator (methyl-ß-cyclodextrin) or a cholesterol-sequestring agent should correlate with the loss of the association of a protein with raft markers.
| RAFTS AS PLATFORMS FOR VIRUS ENTRY |
|---|
|
|
|---|
SV40 initiates infection by binding to the major histocompatibility complex class I molecules (7, 111) which are not targeted to membrane rafts (22). In contrast to viruses that enter cells by typical endocytosis, SV40 is generally considered to penetrate host cells mostly by atypical endocytosis. Biochemical analysis, colocalization studies, and blocking of the virus infection by a dominant negative caveolin showed that this process is mediated by caveolae. Caveolae transport SV40 particles to the ER, where the virus is disassembled (84). It is proposed that SV40 initially binds to major histocompatibility complex class I molecules localized in detergent-soluble membrane and induces a signal which promotes its association with a caveola-containing detergent-insoluble membrane microdomain followed by virus endocytosis (7, 24, 84, 87, 111).
EV1 is internalized into caveolae. It uses
2ß1-integrin as cellular receptor. The subsequent entry results in conformational change of the viral capsids, which can be detected after sedimentation through a sucrose gradient. A follow-up study of the internalization process showed that EV1,
2ß1-integrin, and caveolin-1 were internalized together in vesicular structures and accumulated in a perinuclear compartment. Purified caveolae contained infectious virus. Depletion of cholesterol by incubating cells with the cholesterol-trapping agent methyl-ß-cyclodextrin, or the expression of a dominant negative caveolin markedly inhibit EV1 infection (75).
The use of decay-accelerating factor (DAF or CD55), a GPI-anchored membrane glycoprotein, as receptor by many enteroviruses including enterovirus 70 (57), hemagglutinating echoviruses (11), coxsackievirus B viruses, and coxsackievirus A21 (CAV-21) (82) argues for a possible role of membrane rafts during virus entry. The comparison of DAF-using and non-DAF-using strains of EV11 revealed that DAF-mediated entry is dependent on cholesterol at a postbinding step which precedes the RNA uncoating. The infectivity is blocked by nystatin, a cholesterol-sequestering drug. EV11 copurified with rafts isolated after TX-100 solubilization and sucrose gradient flotation (112).
The receptor of group A rotaviruses (belonging to the Reoviridae family) is a complex of several cell components including gangliosides, Hsc70 protein, and
2ß1- and
Vß3-integrins. All these components might be associated within lipid rafts favoring binding and internalization of rotavirus particles (44, 45).
Four sets of experimental data argue for a role of membrane rafts in the entry of enveloped virus: (i) anchoring of envelope glycoproteins in rafts, (ii) interaction of the virus envelope glycoprotein with a lipid component of cell membrane rafts, (iii) anchoring of the cellular receptor in rafts, and (iv) inhibition of virus entry after cholesterol depletion and/or sequestration.
The glycoproteins of several viruses, including influenza virus, human immunodeficiency virus (HIV), murine leukemia virus (MLV), measles virus, and Ebola virus, are associated with membrane rafts (10, 74, 91, 103, 119). Maturation of gp120-gp41 palmitoylation sites inhibits viral infectivity, but it is not known whether this is due to a direct effect on virus entry or to reduction in the amount of Env protein incorporated into the viral membrane (99).
The low-pH-dependent penetration of the alphavirus Semliki Forest virus (SFV) and Sindbis virus (SIN), both of the family Togaviridae, requires cholesterol in the target membrane (15, 70, 109). Both viruses are strongly dependent on a cholesterol-sphingolipid environment so that they can infect cells via a low-pH-triggered fusion reaction (1, 59, 70, 90, 117, 124). The interaction with cholesterol has been mapped to proline 226 of the SIN E1 spike protein, and a point mutation to alanine results in the loss of cholesterol dependence (70). From studies with liposome, it has been shown that the cholesterol is involved primarily in low-pH-induced virus-liposome binding and the sphingolipid in involved in catalyzing the fusion process. However, SFV and SIN do not seem to require the presence of lipid rafts for fusion with target membranes liposomes because large unilamellar vesicles made of sphingolipids and cholesterol fused to SFV and SIN irrespective of the presence or absence of TX-100-insoluble microdomains (121).
HIV-1 infects permissive cells by binding to CD4, which promotes a conformational change in the surface glycoprotein (gp120), exposing the V3 loop to further interaction with the coreceptors CXCR4 or CCR5. This triggers a conformational change in the transmembrane glycoprotein (gp41), unmasking its fusogenic domain. Glycosphingolipids can act as alternative HIV-1 entry cofactors (35, 47, 51). Physicochemical studies of the interaction of gp120 with different glycosphingolipids, including Gb3 and GM3, have shown that these compounds mediate HIV-1 entry into CXCR4+ and CCR5+ cells, respectively. Primary and/or secondary interactions between a portion of gp120 and glycosphingolipids are probably required for the gp120 and gp41 conformational changes leading to the fusion process. The interaction of gp120 with galactosylceramide involves the V3 loop, and antibodies against galactosylceramide block HIV entry (34). Depletion of target cells in gangliosides reduced the HIV-induced cell-cell fusion, which was restored by the addition of purified Gb3 (51). Moreover, the HIV-1 gp41 envelope residues 650 to 685 act as a lectin to bind epithelial cell galactosylceramide, and antibodies interacting with this sequence block virus entry (2).
Extensive studies have been performed on the localization of CD4 and coreceptors within rafts, which may be a crucial point for the entry of HIV-1 (21, 28, 64, 73). CD4 is undoubtedly a raft-associated component (56, 79, 86), and its retargeting to nonraft membranes by fusion of its ectodomain to the low-density lipoprotein receptor transmembrane region strongly affects the efficiency of HIV entry at a postbinding step (28). While CCR5 is associated with rafts, CXCR4 is not (61, 93). Accordingly, CCR5 is easily coimmunoprecipitated with CD4 whereas CXCR4 is not unless cells have been preincubated with soluble gp120 (126). After incubation with soluble gp120 at 4 or 12°C, lateral association of CD4 and CXCR4 in GM1-rich raft microdomains is observed by confocal microscopy (73, 93), but very little CXCR4 is recovered in TX-100 resistant rafts. When incubated at 37°C, gp120 does not induce any redistribution of CXCR4 in GM1 and CD4 raft microdomains (61). Furthermore, adsorption of HIV particles at 37°C appears to redistribute CD4 outside raft domains. This results suggests that at 37°C, HIV-1 initially binds to CD4 in a raft domain and that the secondary association with CXCR4 requires the shift of proteins and associated lipids away from their preferred lipid environment. This leads to destabilization of the plasma membrane, which may favor the fusion reaction. Rafts would facilitate HIV-1 adsorption onto CD4 and then disperse prior to the ultimate membrane fusion reaction or would stimulate transient CXCR4 motion into rafts as a result of CD4 signaling (61). It should be stressed that the interpretation of the above experiments has to be cautious as far as the relative expression level of CD4 and CXCR4 is concerned: a high expression level will statistically increase the chance of forming loosely interacting complexes of receptor and coreceptor (see below).
Cholesterol depletion of target cells by treatment with methyl-ß-cyclodextrin or cholesterol sequestration by nystatin inhibits HIV-1 infection and syncytium formation (64, 66, 73, 93). This type of approach has severe limitations because such treatment has multiple effects, which tend to affect cell viability and can be quickly reversible on serum addition. Nevertheless, it seems that reduction in the cholesterol level reduces the ability of HIV-1 gp120-gp41 form the receptor-coreceptor clusters required to trigger fusion. Accordingly, a high level of CD4 and CXCR4 expression reduces the effect of cholesterol depletion (118).
HIV-1 Nef protein is targeted to membrane rafts (122) and is present in the virus particles. In the presence of normal amount of cholesterol, Nef significantly enhances HIV-1 infectivity, and this effect is abolished when virus is produced from cholesterol-depleted cells (131). Likewise, cholesterol depletion or sequestration from HIV-1 particles inhibits virus internalization, probably by preventing the fusion step. In contrast to the cholesterol depletion of target cells, incubation of cholesterol-depleted HIV-1 with cholesterol did not result in a recovery of virus internalization (46). Interestingly, in artificial membranes, sphingomyelin and cholesterol promote the surface aggregation of HIV-1 gp41 monomer (100). Replacing the gp160 glycoprotein by the vesicular stomatitis virus (VSV) G protein resulted in pH-dependent virus entry by endocytosis, which is no longer enhanced by the presence of Nef protein (23). Taken together, these data suggest that embedding in a raft can maintain the metastable conformation of fusion-competent gp120-gp41 complex and/or participate in destabilization of the bilayer architecture at the loci of fusion.
Besides these putative direct roles of membrane rafts in HIV-1 entry, the presence of other cellular factors targeted to rafts may promote virus entry. It is important to point out that the penetration of HIV-1 through rafts may direct HIV-1 preintegration complexes into a favorable compartment for a productive infection. It is tempting to speculate that the increased local concentration of receptors, coreceptors, or some other interacting proteins, at a given moment within rafts, can be due in part to the stimulation of signaling pathways within these microdomains. Indeed, the expression of flotillin-1, a protein enriched in lipid rafts and involved in the fusion process, is induced by gp120 binding (25, 29, 64). Likewise, the anchorage of HIV-1 may lead to the accumulation of surface nucleolin within lipid rafts (83). Finally, HIV-1 nonproductively infects brain microvascular endothelial cells via a macropinocytosis mechanism which is dependent on lipid raft integrity and on the mitogen-activated protein kinase signaling pathway (66).
Some enveloped viruses seem to be internalized by endocytosis within caveolae. The cellular receptor of ecotropic MLV is a transmembrane protein named CAT1. It is involved into the transport of cationic amino acids into cells and is physically associated with caveolin in membrane rafts. The disruption of rafts inhibits an early step of ecotropic MLV infection, suggesting that the localization of the receptor within rafts is important for the virus entry step (68). Cholesterol in the target membrane but not in the membrane containing the virus glycoprotein plays a crucial role in enabling membrane fusion (69). The entry of filoviruses such as Ebola virus and Marburg virus is inhibited after cholesterol depletion of the target cells, and after internalization, viral proteins co localized with caveolin as shown by confocal microscopy (33). The putative role of caveolae in mediating MLV and filovirus entry will have to be confirmed by using a dominant negative caveolin.
In summary, further studies should be performed to understand the implication of lipid domains and the molecular organization of cell membranes in the kinetics of events leading to virus entry. The underlying mechanism of the role of membrane rafts in the fusion step of enveloped viruses is unclear. Nevertheless, the available data suggest that rafts might be a platform for virus entry by providing local concentrations of receptors and/or receptor-coreceptor complexes as well as other cell components which can modulate the entry process. However, the composition of the virus envelope also needs to be carefully studies. Some viruses have envelopes made from rafts, and they may or may not require rafts in the target membrane for entry. The way in which some signaling pathways can drive the coalescence of all the components involved in virus entry remains to be determined.
| RAFTS AS PLATFORMS FOR VIRUS ASSEMBLY |
|---|
|
|
|---|
|
|
|
Rafts may be also used by Sendai virus as assembly platforms. When the matrix protein (M), which plays a critical role in Sendai virus assembly, is expressed alone, it is preferentially associated with nonraft membranes, but when M is coexpressed with F or HN glycoproteins, either individually or together, it becomes resistant to an unusually low concentration of TX-100 (4).
When studying the involvement of rafts in the virus assembly process, one has to keep in mind that in contrast to GPI-anchored proteins, only a fraction of viral proteins are found associated with rafts. This could be due to the poor biochemical characterization of rafts subsets or to the transient nature of the association. The elucidation of raft involvement in viral assembly step will have to be more precisely defined by expressing individual viral components independently or together and by using complementary technical approaches. Indeed, available data on raft involvement in the virus life cycle are mostly restricted to the simple descriptions of the distribution of viral proteins within rafts following detergent solubilization and cholesterol depletion.
| RAFTS AS PLATFORMS FOR VIRUS BUDDING |
|---|
|
|
|---|
During the release of enveloped viruses into the extracellular environment, membrane lipids are not randomly incorporated into viral envelope. Virions can have a specific lipid composition different from that of the host cell membrane. Fowl plague virus, which belongs to the influenza virus family, contains large amounts of detergent-insoluble complexes, whereas such complexes are largely absent from the VSV and SFV envelopes (102). The lipid composition of the influenza virus family is due to the intrinsic affinity of the HA and NA glycoproteins for these lipids, as shown by the lower contents of virus envelope in raft lipids when both glycoproteins lacking their cytoplasmic tails are less likely to associate with rafts (130). This suggests that influenza virus buds from raft domains. However, controversial data were obtained for VSV and SFV. The lipid analysis of VSV particles by fluorescence digital microscopy indicates the formation of lipid domains during the budding steps. Both the glycoprotein and the matrix protein induce lateral organization of lipids within the membrane, and the lipid composition of the VSV envelope differs from that of the host cell, suggesting that VSV might bud from "classic" rafts or from a subgroup of rafts (71, 89).
After the assembly of measles virus within membrane rafts, the envelope-RNP complex appears ready for budding. This virus is rather inefficient in budding, and single particles contain several RNPs (95). Viruses released into cell-free supernatant are made partially of nonraft membranes, with recovery in detergent-resistant membrane rafts of H and F glycoproteins but no other viral structural proteins (74). Thus, either the particles assembled in membrane rafts are not precursors of budding mature viruses or, after assembly involving the coalescence of several membrane rafts, virus budding through membrane rafts is associated with the capture of adjacent nonraft membranes and simultaneously initiates a shift of the RNPs from raft to nonraft regions. Two observations argue for the latter hypothesis: (i) whereas RNPs are tightly bound to the plasma membrane of infected cells, they tend to dissociate from the virus envelope after budding (31), and (ii) there is a correlation between a defect in measles virus budding in a murine cell line (120) and the poor localization of the M protein in membrane rafts from infected cells (S. Vincent and D. Gerlier, unpublished data). Demonstration of a raft requirement for measles virus budding awaits further experimental evidence.
Many arguments favor a raft membrane dependence for HIV budding. Treatment of human T lymphocytes cultured in cholesterol-poor medium with lovastatin, an inhibitor of cholesterol synthesis, inhibits HIV-1 production (77). The exclusion of the abundant nonraft CD45 phosphatase from the HIV-1 envelope and the incorporation of raft lipid components (ganglioside GM1) and resident proteins (the GPI-anchored proteins Thy-1 and CD59) indicates that HIV-1 specifically buds from rafts (80). The blocking of HIV-1 budding after treatment of cells with unsaturated fatty acid directly indicates a critical role of rafts in virus budding. This treatment inhibits Pr55gag targeting to rafts without affecting its association with cell membranes and significantly reduces the number of virus-like particles released into the supernatant (65). The Nef protein, which is recruited into the virus at the raft assembly site, enhances virus release and infectivity (23, 27). Thus, Nef probably participates directly in the formation of the budding scaffold. However, one has to keep in mind that any biochemical data on HIV-1 (and many enveloped virus) relies on the analysis of purified particles, which are hardly devoid of contaminating cell membrane sheets (12, 42).
| CONCLUDING REMARKS AND PROSPECTS |
|---|
|
|
|---|
The evidence for a great heterogeneity in membrane lipids and their organization in various domains such as rafts has provided new tools to explore the molecular mechanism underlying virus entry, assembly, and budding. It should be stressed that when studying rafts, what matters is the efficiency of the molecule partition within highly exchangeable lipid microdomains. Therefore, one cannot expect to observe all-or-none phenotypes when attempting to modify raft structure and/or composition. It is very likely that rafts act basically as a planar lipid milieu favoring interactions between molecules which have some intrinsic affinity to each other.
The caveolae, a subset of membrane rafts, are critically involved in the entry of SV40 and EV1. Likewise, embedding of the HIV-1 gp120-gp41 glycoproteins in membrane rafts is required for proper folding and fusion competence. Furthermore, due to their ability to coalesce after cross-linking signals, membrane rafts may control the appropriate clustering of cellular lipid and protein receptors to enable HIV-1 entry.
The opportunity to isolate membrane rafts has allowed us to determine how the H and F envelope glycoproteins and RNPs under scaffolding can reach a common sub membrane location to assemble into a functional measles virus-like particle. A more systematic study of the assembly of all influenza virus components within membrane rafts is likely to be most informative. Likewise, membrane rafts are probably critical for efficient HIV-1 assembly.
Virus budding from membrane rafts does occur, at least for influenza virus and HIV-1, but whether rafts are absolutely required for virus budding is unknown. Solving this question will require the refinement of the raft subset structures, raft lipid boundaries, and raft dynamics. Nevertheless, by carrying accessory proteins, rafts are likely to contribute to the optimization of virus infectivity, as illustrated by the incorporation of Nef into HIV-1 particles.
The following questions need to be addressed in order to decipher any role of membrane rafts in the replication cycle of a virus. Are specific raft subsets involved? Which viral protein (virus receptor) can reach rafts on its own? What are the underlying molecular mechanisms or evidence for specific raft-targeting motif? Which viral protein (virus receptor) is brought about by a partner intrinsically targeted to the raft, and how is this done? Other important questions remain to be answered. What is the role of the cell molecule partners: as cargo for targeting to rafts or as a useful virus cofactor which can thus be efficiently embarked? Are rafts a (compulsory) intermediate oligomerization platform for virus scaffolding? Do raft dynamics control the oligomerization and maturation steps which convert an immature capsid shell into a metastable mature core, ready for uncoating? What is the advantage that viruses gain when using rafts? Do rafts promote local concentrations of useful (cell or virus) molecular partners including specific lipids? Do they promote conformational changes of virus scaffolding components? Do they promote activation (or silencing) of viral or cellular enzymatic activity? Do they promote fusion and/or capsid penetration? Do they promote cell signaling useful for virus replication?
Answering these questions will require the use of several independent approaches such as biochemical purification of rafts after detergent solubilization, colocalization and biosynthesis studies, and reconstitution experiments in artificial bilayers. In any case, one should keep in mind that biochemical characterization of rafts critically relies on the nature of the detergent and the physicochemical conditions of its use. A given detergent exhibits different solubilizing properties toward a class of lipids and protein. These solubilizing properties are modulated by temperature, detergent-to-membrane ratio, pH, and ionic strength (8). Furthermore, rafts are highly dynamic entities: within minutes of receptor stimulation, the raft protein composition drastically changes, with only a small percentage of proteins remaining invariable (13).
Elucidation of the involvement of rafts in the viral life cycle should help to define more precisely the main events of the viral infectious cycle and to provide some clues to fundamental biology. It may also serve to develop new antiviral strategies and to guide the engineering of recombinant viruses useful as experimental tools or therapeutic agents.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the Agence Nationale de la Recherche sur le Sida, Ensemble contre le SidaCS/Sidaction, and the Programme de Recherche Fondamental en Microbiologie, Maladies Infectieuses et Parasitaires.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Ahn, A., D. L. Gibbons, and M. Kielian. 2002. The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains. J. Virol. 76:3267-3275. |
| 2. | Alfsen, A., and M. Bomsel. 2002. HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. J. Biol. Chem. 277:25649-25659. |
| 3. | Ali, A., R. T. Avalos, E. Ponimaskin, and D. P. Nayak. 2000. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J. Virol. 74:8709-8719. |
| 4. | Ali, A., and D. P. Nayak. 2000. Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology 276:289-303.[CrossRef][Medline] |
| 5. | Aloia, R. C., H. Tian, and F. C. Jensen. 1993. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. USA 90:5181-5185. |
| 6. | Alonso, M. A., and J. Millan. 2001. The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J. Cell Sci. 114:3957-3965.[Medline] |
| 7. | Anderson, H. A., Y. Chen, and L. C. Norkin. 1998. MHC class I molecules are enriched in caveolae but do not enter with simian virus 40. J. Gen. Virol. 79:1469-1477.[Abstract] |
| 8. | Banerjee, P., J. B. Joo, J. T. Buse, and G. Dawson. 1995. Differential solubilization of lipids along with membrane proteins by different classes of detergents. Chem. Phys. Lipids 77:65-78.[CrossRef][Medline] |
| 9. | Barman, S., and D. P. Nayak. 2000. Analysis of the transmembrane domain of influenza virus neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association. J. Virol. 74:6538-6545. |
| 10. | Bavari, S., C. M. Bosio, E. Wiegand, G. Ruthel, A. B. Will, T. W. Geisbert, M. Hevey, C. Schmaljohn, A. Schmaljohn, and M. J. Aman. 2002. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 195:593-602. |
| 11. | Bergelson, J. M., M. Chan, K. R. Solomon, N. F. St John, H. Lin, and R. W. Finberg. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA 91:6245-6249. |
| 12. | Bess, J. W., Jr., R. J. Gorelick, W. J. Bosche, L. E. Henderson, and L. O. Arthur. 1997. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology 230:134-144.[CrossRef][Medline] |
| 13. | Bini, L., S. Pacini, S. Liberatore, S. Valensin, M. Pellegrini, R. Raggiashi, V. Pallini, and C. T. Baldari. 2003. Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering. Biochem. J. 369:301-309.[CrossRef][Medline] |
| 14. | Bohn, W., G. Rutter, H. Hohenberg, K. Mannweiler, and P. Nobis. 1986. Involvement of actin filaments in budding of measles virus: studies on cytoskeletons of infected cells. Virology 149:91-106.[CrossRef][Medline] |
| 15. | Bron, R., J. M. Wahlberg, H. Garoff, and J. Wilschut. 1993. Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein. EMBO J. 12:693-701.[Medline] |
| 16. | Brown, D. A., and E. London. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275:17221-17224. |
| 17. | Brown, D. A., and E. London. 1998. Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol. 164:103-114.[CrossRef][Medline] |
| 18. | Brown, G., J. Aitken, H. W. Rixon, and R. J. Sugrue. 2002. Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells. J. Gen. Virol. 83:611-621. |
| 19. | Brown, G., H. W. Rixon, and R. J. Sugrue. 2002. Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1. J. Gen. Virol. 83:1841-1850. |
| 20. | Caballero, M., J. Carabana, J. Ortego, R. Fernandez-Munoz, and M. L. Celma. 1998. Measles virus fusion protein is palmitoylated on transmembrane-intracytoplasmic cysteine residues which participate in cell fusion. J. Virol. 72:8198-8204. |
| 21. | Campbell, S. M., S. M. Crowe, and J. Mak. 2001. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J. Clin. Virol. 22:217-227.[CrossRef][Medline] |
| 22. | Cerny, J., H. Stockinger, and V. Horejsi. 1996. Noncovalent associations of T lymphocyte surface proteins. Eur. J. Immunol. 26:2335-2343.[Medline] |
| 23. | Chazal, N., G. Singer, C. Aiken, M. L. Hammarskjold, and D. Rekosh. 2001. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J. Virol. 75:4014-4018. |
| 24. | Chen, Y., and L. C. Norkin. 1999. Extracellular simian virus 40 transmits a signal that promotes virus enclosure within caveolae. Exp. Cell Res. 246:83-90.[CrossRef][Medline] |
| 25. | Cicala, C., J. Arthos, S. M. Selig, G. Dennis, Jr., D. A. Hosack, D. Van Ryk, M. L. Spangler, T. D. Steenbeke, P. Khazanie, N. Gupta, J. Yang, M. Daucher, R. A. Lempicki, and A. S. Fauci. 2002. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc. Natl. Acad. Sci. USA 99:9380-9385. |
| 26. | Cleverley, D. Z., H. M. Geller, and J. Lenard. 1997. Characterization of cholesterol-free insect cells infectible by baculoviruses: effects of cholesterol on VSV fusion and infectivity and on cytotoxicity induced by influenza M2 protein. Exp. Cell Res. 233:288-296.[CrossRef][Medline] |
| 27. | Cullen, B. R. 1998. HIV-1 auxiliary proteins: making connections in a dying cell. Cell 93:685-692.[CrossRef][Medline] |
| 28. | Del Real, G., S. Jimenez-Baranda, R. A. Lacalle, E. Mira, P. Lucas, C. Gomez-Mouton, A. C. Carrera, A. C. Martinez, and S. Manes. 2002. Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains. J. Exp. Med. 196:293-301. |
| 29. | Dermine, J. F., S. Duclos, J. Garin, F. St Louis, S. Rea, R. G. Parton, and M. Desjardins. 2001. Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes. J. Biol. Chem. 276:18507-18512. |
| 30. | Dietrich, C., L. A. Bagatolli, Z. N. Volovyk, N. L. Thompson, M. Levi, K. Jacobson, and E. Gratton. 2001. Lipid rafts reconstituted in model membranes. Biophys. J. 80:1417-1428. |
| 31. | Dubois-Dalcq, M., and T. S. Reese. 1975. Structural changes in the membrane of vero cells infected with a paramyxovirus. J. Cell Biol. 67:551-565. |
| 32. | Echarri, A., M. E. Gonzalez, and L. Carrasco. 1996. Human immunodeficiency virus (HIV) Nef is an RNA binding protein in cell-free systems. J. Mol. Biol. 262:640-651.[CrossRef][Medline] |
| 33. | Empig, C. J., and M. A. Goldsmith. 2002. Association of the caveola vesicular system with cellular entry by filoviruses. J. Virol. 76:5266-5270. |
| 34. | Fantini, J., D. G. Cook, N. Nathanson, S. L. Spitalnik, and F. Gonzalez-Scarano. 1993. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. USA 90:2700-2704. |
| 35. | Fantini, J., D. Hammache, O. Delezay, N. Yahi, C. Andre-Barres, I. Rico-Lattes, and A. Lattes. 1997. Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry. J. Biol. Chem. 272:7245-7252. |
| 36. | Fournier, C., J. C. Cortay, C. Carbonnelle, C. Ehreshmann, R. Marquet, and P. Boulanger. 2002. The HIV-1 Nef protein enhances the affinity of reverse transcriptase for RNA in vitro. Virus Genes 25:253-267. |
| 37. | Freed, E. O. 2002. Viral late domains. J. Virol. 76:4679-4687. |
| 38. | Friedrichson, T., and T. V. Kurzchalia. 1998. Microdomains of GPI-anchored proteins in living cells revealed by crosslinking. Nature 394:802-805.[CrossRef][Medline] |
| 39. | Fuller, S., C. H. von Bonsdorff, and K. Simons. 1984. Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell 38:65-77.[CrossRef][Medline] |
| 40. | Garnier, L., J. B. Bowzard, and J. W. Wills. 1998. Recent advances and remaining problems in HIV assembly. AIDS 12(Suppl. A):S5-S16.[Medline] |
| 41. | Garoff, H., R. Hewson, and D. J. Opstelten. 1998. Virus maturation by budding. Microbiol. Mol. Biol. Rev. 62:1171-1190. |
| 42. | Gluschankof, P., I. Mondor, H. R. Gelderblom, and Q. J. Sattentau. 1997. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology 230:125-133.[CrossRef][Medline] |
| 43. | Gottlinger, H. G. 2001. The HIV-1 assembly machine. AIDS 15(Suppl. 5):S13-S20.[CrossRef] |
| 44. | Guerrero, C. A., D. Bouyssounade, S. Zarate, P. Isa, T. Lopez, R. Espinosa, P. Romero, E. Mendez, S. Lopez, and C. F. Arias. 2002. Heat shock cognate protein 70 is involved in rotavirus cell entry. J. Virol. 76:4096-4102. |
| 45. | Guerrero, C. A., S. Zarate, G. Corkidi, S. Lopez, and C. F. Arias. 2000. Biochemical characterization of rotavirus receptors in MA104 cells. J. Virol. 74:9362-9371. |
| 46. | Guyader, M., E. Kiyokawa, L. Abrami, P. Turelli, and D. Trono. 2002. Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J. Virol. 76:10356-10364. |
| 47. | Hammache, D., G. Pieroni, N. Yahi, O. Delezay, N. Koch, H. Lafont, C. Tamalet, and J. Fantini. 1998. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J. Biol. Chem. 273:7967-7971. |
| 48. | Harder, T., and K. Simons. 1997. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr. Opin. Cell Biol. 9:534-542.[CrossRef][Medline] |
| 49. | Henderson, G., J. Murray, and R. P. Yeo. 2002. Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins. Virology 300:244-254.[CrossRef][Medline] |
| 50. | Huang, X., T. Liu, J. Muller, R. A. Levandowski, and Z. Ye. 2001. Effect of influenza virus matrix protein and viral RNA on ribonucleoprotein formation and nuclear export. Virology 287:405-416.[CrossRef][Medline] |
| 51. | Hug, P., H. M. Lin, T. Korte, X. Xiao, D. S. Dimitrov, J. M. Wang, A. Puri, and R. Blumenthal. 2000. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J. Virol. 74:6377-6385. |
| 52. | Hughey, P. G., R. W. Compans, S. L. Zebedee, and R. A. Lamb. 1992. Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells. J. Virol. 66:5542-5552. |
| 53. | Huttner, W. B., and J. Zimmerberg. 2001. Implications of lipid microdomains for membrane curvature, budding and fission. Curr. Opin. Cell Biol. 13:478-484.[CrossRef][Medline] |
| 54. | Jackson, D. C., X. L. Tang, K. G. Murti, R. G. Webster, G. W. Tregear, and W. J. Bean. 1991. Electron microscopic evidence for the association of M2 protein with the influenza virion. Arch. Virol. 118:199-207.[CrossRef][Medline] |
| 55. | Jacobson, K., and C. Dietrich. 1999. Looking at lipid rafts? Trends Cell Biol. 9:87-91.[CrossRef][Medline] |
| 56. | Janes, P. W., S. C. Ley, and A. I. Magee. 1999. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J. Cell Biol. 147:447-461. |
| 57. | Karnauchow, T. M., D. L. Tolson, B. A. Harrison, E. Altman, D. M. Lublin, and K. Dimock. 1996. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 70:5143-5152.[Abstract] |
| 58. | Keller, P., and K. Simons. 1998. Cholesterol is required for surface transport of influenza virus hemagglutinin. J. Cell Biol. 140:1357-1367. |
| 59. | Kielian, M. C., and A. Helenius. 1984. Role of cholesterol in fusion of Semliki Forest virus with membranes. J. Virol. 52:281-283. |
| 60. | Kikonyogo, A., F. Bouamr, M. L. Vana, Y. Xiang, A. Aiyar, C. Carter, and J. Leis. 2001. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc. Natl. Acad. Sci. USA 98:11199-11204. |
| 61. | Kozak, S. L., J. M. Heard, and D. Kabat. 2002. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J. Virol.76:1802-1815. |
| 62. | Lee, A. 2001. Membrane structure. Curr. Biol. 11:R811-R814.[CrossRef][Medline] |
| 63. | Lee, Y. M., B. Liu, and X. F. Yu. 1999. Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes. J. Virol. 73:5654-5662. |
| 64. | Liao, Z., L. M. Cimakasky, R. Hampton, D. H. Nguyen, and J. E. Hildreth. 2001. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses 17:1009-1019.[CrossRef][Medline] |
| 65. | Lindwasser, O. W., and M. D. Resh. 2002. Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc. Natl. Acad. Sci. USA 99:13037-13042. |
| 66. | Liu, N. Q., A. S. Lossinsky, W. Popik, X. Li, C. Gujuluva, B. Kriederman, J. Roberts, T. Pushkarsky, M. Bukrinsky, M. Witte, M. Weinand, and M. Fiala. 2002. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J. Virol. 76:6689-6700. |
| 67. | Lodge, R., H. Gottlinger, D. Gabuzda, E. A. Cohen, and G. Lemay. 1994. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 68:4857-4861. |
| 68. | Lu, X., and J. Silver. 2000. Ecotropic murine leukemia virus receptor is physically associated with caveolin and membrane rafts. Virology 276:251-258.[CrossRef][Medline] |
| 69. | Lu, X., Y. Xiong, and J. Silver. 2002. Asymmetric requirement for cholesterol in receptor-bearing but not envelope-bearing membranes for fusion mediated by ecotropic murine leukemia virus. J. Virol. 76:6701-6709. |
| 70. | Lu, Y. E., T. Cassese, and M. Kielian. 1999. The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J. Virol. 73:4272-4278. |
| 71. | Luan, P., L. Yang, and M. Glaser. 1995. Formation of membrane domains created during the budding of vesicular stomatitis virus. A model for selective lipid and protein sorting in biological membranes. Biochemistry 34:9874-9883.[CrossRef][Medline] |
| 72. | Madore, N., K. L. Smith, C. H. Graham, A. Jen, K. Brady, S. Hall, and R. Morris. 1999. Functionally different GPI proteins are organized in different domains on the neuronal surface. EMBO J. 18:6917-6926.[CrossRef][Medline] |
| 73. | Manes, S., G. del Real, R. A. Lacalle, P. Lucas, C. Gomez-Mouton, S. Sanchez-Palomino, R. Delgado, J. Alcami, E. Mira, and A. C. Martinez. 2000. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 1:190-196.[CrossRef][Medline] |
| 74. | Manie, S. N., S. Debreyne, S. Vincent, and D. Gerlier. 2000. Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J. Virol. 74:305-311. |
| 75. | Marjomaki, V., V. Pietiainen, H. Matilainen, P. Upla, J. Ivaska, L. Nissinen, H. Reunanen, P. Huttunen, T. Hyypia, and J. Heino. 2002. Internalization of echovirus 1 in caveolae. J. Virol. 76:1856-1865. |
| 76. | Martin, K., and A. Helenius. 1991. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117-130.[CrossRef][Medline] |
| 77. | Maziere, J. C., J. C. Landureau, P. Giral, M. Auclair, L. Fall, A. Lachgar, A. Achour, and D. Zagury. 1994. Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor medium. Biomed. Pharmacother. 48:63-67.[CrossRef][Medline] |
| 78. | Melkonian, K. A., A. G. Ostermeyer, J. Z. Chen, M. G. Roth, and D. A. Brown. 1999. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J. Biol. Chem. 274:3910-3917. |
| 79. | Millan, J., J. Cerny, V. Horejsi, and M. A. Alonso. 1999. CD4 segregates into specific detergent-resistant T-cell membrane micr |